OPKO Health Q2 EPS $(0.03) Beats $(0.07) Estimate, Sales $265.40M Beat $201.97M Estimate
Portfolio Pulse from totan@benzinga.com
OPKO Health reported Q2 earnings per share (EPS) of $(0.03), beating the analyst consensus estimate of $(0.07) by 57.14%. This is a 78.57% increase over losses from the same period last year. The company also reported quarterly sales of $265.40 million, beating the analyst consensus estimate of $201.97 million by 31.41%. However, this is a 14.36% decrease over sales from the same period last year.
August 04, 2023 | 2:24 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
OPKO Health's Q2 earnings beat estimates, with EPS beating by 57.14% and sales beating by 31.41%. However, sales are down 14.36% from the same period last year.
OPKO Health's Q2 earnings beat estimates, which is generally positive news for the company's stock. However, the decrease in sales compared to the same period last year could potentially offset some of this positive impact.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100